Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Celecoxib × 30 days × Clear all

Phase

Phase 2 5 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioma 1

Interventions

Specimen Handling 87 Biopsy 67 pembrolizumab 61 Magnetic Resonance Spectroscopy 60 Cyclophosphamide 47 Nivolumab 35 venetoclax 29 fludarabine 28 Cetuximab 23 Radiotherapy 20 Fluorouracil 20 Carboplatin 20 Gemcitabine 19 Cisplatin 19 Bevacizumab 18 Ipilimumab 17 Oxaliplatin 16 Cytarabine 16 Azacitidine 16 atezolizumab 15 Paclitaxel 15 Leucovorin 14 tislelizumab 13 fludarabine phosphate 13 X-Rays 13 Temozolomide 13 Radiosurgery 13 Prednisone 12 Lenalidomide 12 Irinotecan 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02115074 2026-03-18

FLUVABREX

Centre Oscar Lambret

Phase 1 Completed

Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡